Menu

Media & Insight

Lila Hope

2023 Business Outlook Resources

Insights and strategies for companies navigating today’s evolving economic conditions • December 29, 2022
Opthea Secures $170 Million Financing and $90 Million Private Placement

Proceeds to advance phase 3 clinical trials and pre-commercialization activities of lead drug candidate OPT-302 • August 23, 2022

Chambers USA 2022 Recognizes Cooley Lawyers + Practices

June 2, 2022
Lulu’s – $92 Million IPO

November 17, 2021

Singapore’s Engine Biosciences Raises $43 Million to Decipher Genetic Codes for New Medicines

June 17, 2021
Chambers USA 2021 Recognizes Cooley Lawyers + Practices

May 28, 2021

Cooley’s 2020 Life Sciences M&A Year in Review

Cooley M&A • January 22, 2021
I-Mab Enters Global Strategic Partnership With AbbVie for Cancer Treatment

September 10, 2020

Legal 500 US 2020 Highlights Cooley

June 24, 2020
Chambers USA 2020 Recognizes Cooley Lawyers + Practices

May 13, 2020

Portola Agrees to Sell to Alexion for $1.41 Billion

May 5, 2020
Goldfinch Partners With Gilead to Develop Novel Therapies for Kidney Disease

June 4, 2019

Gossamer Bio – $317 Million IPO

One of the largest healthcare IPOs of the last 20 years • February 21, 2019
SoftBank Vision Fund Leads $400 Million Series C for Relay Therapeutics

December 27, 2018

SoftBank Vision Fund Leads $1.1 Billion Financing of Roivant Sciences

August 14, 2017
Cour and Takeda Partner to Treat Celiac Disease

December 10, 2015

Nexvet Biopharma Closes Initial Public Offering

February 13, 2015
Ascendis Pharma Closes $124 Million Initial Public Offering

February 13, 2015

CardioKinetix Completes $50 Million Financing

December 19, 2014
Cooley Advises MyoKardia on Collaboration with Sanofi

September 23, 2014

Cooley Advises Adamas Pharmaceuticals on Initial Public Offering

April 30, 2014
Cooley Advises Portola Pharmaceuticals on its $140 Million IPO

May 29, 2013